Northern Trust’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Buy
655,131
+261,083
+66% +$612K ﹤0.01% 3212
2025
Q4
$1.07M Sell
394,048
-4,851
-1% -$15.9K ﹤0.01% 3341
2025
Q3
$1.69M Sell
398,899
-4,152
-1% -$18.3K ﹤0.01% 3126
2025
Q2
$2.01M Sell
403,051
-8,903
-2% -$38.7K ﹤0.01% 2986
2025
Q1
$1.82M Sell
411,954
-9,856
-2% -$46.3K ﹤0.01% 2972
2024
Q4
$1.96M Buy
421,810
+50,256
+14% +$276K ﹤0.01% 3040
2024
Q3
$2.58M Sell
371,554
-4,683
-1% -$36.8K ﹤0.01% 2843
2024
Q2
$2.93M Sell
376,237
-2,616
-0.7% -$19.4K ﹤0.01% 2693
2024
Q1
$2.69M Sell
378,853
-5,914
-2% -$39.1K ﹤0.01% 2811
2023
Q4
$2.58M Buy
384,767
+193,557
+101% +$1.09M ﹤0.01% 2858
2023
Q3
$1.08M Sell
191,210
-164,319
-46% -$1.1M ﹤0.01% 3270
2023
Q2
$1.96M Sell
355,529
-15,168
-4% -$81.6K ﹤0.01% 3017
2023
Q1
$2.32M Sell
370,697
-1,283
-0.3% -$7.15K ﹤0.01% 2875
2022
Q4
$1.73M Buy
371,980
+36,608
+11% +$180K ﹤0.01% 3068
2022
Q3
$1.57M Buy
335,372
+192,761
+135% +$1.22M ﹤0.01% 3136
2022
Q2
$844K Buy
142,611
+22,246
+18% +$248K ﹤0.01% 3387
2022
Q1
$2.33M Buy
120,365
+6,928
+6% +$159K ﹤0.01% 3024
2021
Q4
$3.71M Sell
113,437
-4,828
-4% -$194K ﹤0.01% 2884
2021
Q3
$4.85M Sell
118,265
-694
-0.6% -$25.2K ﹤0.01% 2752
2021
Q2
$4.28M Buy
118,959
+43,219
+57% +$1.59M ﹤0.01% 2938
2021
Q1
$2.96M Buy
75,740
+5,140
+7% +$231K ﹤0.01% 3043
2020
Q4
$2.85M Buy
+70,600
New +$3.24M ﹤0.01% 3001

Other funds holding GDRX

Northern Trust's GDRX Position: Q1 2026 in Review

Northern Trust increased its GoodRx Holdings (GDRX) stake by 66% in Q1 2026, buying an estimated $612K and bringing the position to 655,131 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3212.

Northern Trust first reported a position in GDRX in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.85M in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Northern Trust held 655,131 shares of GoodRx Holdings worth $1.28M as of Q1 2026.
  • Northern Trust bought 261,083 GoodRx Holdings shares in Q1 2026, an estimated $612K.
  • GoodRx Holdings made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3212 holding.
  • Northern Trust first reported a position in GoodRx Holdings in Q4 2020 and has held it in 22 quarters since.
  • Northern Trust's GoodRx Holdings position peaked at $4.85M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.